Transcriptomic Analysis of Cell-free Fetal RNA Suggests a Specific Molecular Phenotype in Trisomy 18

Overview

Journal Hum Genet

Specialty Genetics

Date 2010 Dec 15

PMID 21152935

Citations 32

Authors

Keiko Koide

Donna K Slonim

Kirby L Johnson

Umadevi Tantravahi

Janet M Cowan

Diana W Bianchi

Affiliations

Soon will be listed here.

Abstract

Trisomy 18 is a common human aneuploidy that is associated with significant perinatal mortality. Unlike the well-characterized "critical region" in trisomy 21 (21q22), there is no corresponding region on chromosome 18 associated with its pathogenesis. The high morbidity and mortality of affected individuals has limited extensive investigations. In order to better understand the molecular mechanisms underlying the congenital anomalies observed in this condition, we investigated the in utero gene expression profile of second trimester fetuses affected with trisomy 18. Total RNA was extracted from cell-free amniotic fluid supernatant from aneuploid fetuses and euploid controls matched for gestational age and hybridized to Affymetrix U133 Plus 2.0 arrays. Individual differentially expressed transcripts were obtained by two-tailed t tests. Over-represented functional pathways among these genes were identified with DAVID and Ingenuity(®) Pathways Analysis. Results show that three hundred and fifty-two probe sets representing 251 annotated genes were statistically significantly differentially expressed between trisomy 18 and controls. Only 7 genes (2.8% of the annotated total) were located on chromosome 18, including ROCK1, an up-regulated gene involved in valvuloseptal and endocardial cushion formation. Pathway analysis indicated disrupted function in ion transport, MHCII/T cell mediated immunity, DNA repair, G-protein mediated signaling, kinases, and glycosylation. Significant down-regulation of genes involved in adrenal development was identified, which may explain both the abnormal maternal serum estriols and the pre and postnatal growth restriction in trisomy 18. Comparison of this gene set to one previously generated for trisomy 21 fetuses revealed only six overlapping differentially regulated genes. This study contributes novel information regarding functional developmental gene expression differences in fetuses with trisomy 18.

Citing Articles

A Patient Diagnosed with Mosaic Trisomy 18 Presenting New Symptoms: Diaphragmatic Relaxation and Cyclic Vomiting Syndrome. Updated Review of Mosaic Trisomy 18 Cases.

Kosa M, Horvath E, Kalmar T, Maroti Z, Foldesi I, Bereczki C J Pediatr Genet. 2024; 13(4):320-325.

PMID: 39502855 PMC: 11534437. DOI: 10.1055/s-0042-1757621.

Pre-pregnancy BMI, gestational weight gain, and telomere length in amniotic fluid: a causal graph analysis.

Barchitta M, Maugeri A, La Mastra C, Favara G, La Rosa M, Magnano San Lio R Sci Rep. 2024; 14(1):23396.

PMID: 39379607 PMC: 11461511. DOI: 10.1038/s41598-024-74765-y.

A Framework for Understanding Maternal Immunity.

Bonney E Immunol Allergy Clin North Am. 2023; 43(1S):e1-e20.

PMID: 37179052 PMC: 10484232. DOI: 10.1016/j.iac.2023.03.002.

Emerging technologies for prenatal diagnosis: The application of whole genome and RNA sequencing.

Liu P, Vossaert L Prenat Diagn. 2022; 42(6):686-696.

PMID: 35416301 PMC: 10014115. DOI: 10.1002/pd.6146.

Single-Cell Transcriptomics of Cultured Amniotic Fluid Cells Reveals Complex Gene Expression Alterations in Human Fetuses With Trisomy 18.

Wang J, Chen Z, He F, Lee T, Cai W, Chen W Front Cell Dev Biol. 2022; 10:825345.

PMID: 35392164 PMC: 8980718. DOI: 10.3389/fcell.2022.825345.

References

Matsuoka R, Matsuyama S, Yamamoto Y, Kuroki Y, Matsui I . Trisomy 18q. A case report and review of karyotype-phenotype correlations. Hum Genet. 1981; 57(1):78-82. DOI: 10.1007/BF00271173. View

Bettio D, Setti P, Bianchi P, Grazioli V . Trisomy 18 mosaicism in a woman with normal intelligence. Am J Med Genet A. 2003; 120A(2):303-4. DOI: 10.1002/ajmg.a.20213. View

Smith D, PATAU K, THERMAN E, Inhorn S . A new autosomal trisomy syndrome: multiple congenital anomalies caused by an extra chromosome. J Pediatr. 1960; 57:338-45. DOI: 10.1016/s0022-3476(60)80241-7. View

Ashburner M, Ball C, Blake J, Botstein D, Butler H, Cherry J . Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000; 25(1):25-9. PMC: 3037419. DOI: 10.1038/75556. View

Edwards J, HARNDEN D, Cameron A, CROSSE V, Wolff O . A new trisomic syndrome. Lancet. 1960; 1(7128):787-90. DOI: 10.1016/s0140-6736(60)90675-9. View

Mootha V, Lindgren C, Eriksson K, Subramanian A, Sihag S, Lehar J . PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003; 34(3):267-73. DOI: 10.1038/ng1180. View

Subramanian A, Tamayo P, Mootha V, Mukherjee S, Ebert B, Gillette M . Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005; 102(43):15545-50. PMC: 1239896. DOI: 10.1073/pnas.0506580102. View

Embleton N, Wyllie J, Wright M, Burn J, Hunter S . Natural history of trisomy 18. Arch Dis Child Fetal Neonatal Ed. 1996; 75(1):F38-41. PMC: 1061148. DOI: 10.1136/fn.75.1.f38. View

Morris J, Savva G . The risk of fetal loss following a prenatal diagnosis of trisomy 13 or trisomy 18. Am J Med Genet A. 2008; 146A(7):827-32. DOI: 10.1002/ajmg.a.32220. View

10.

VAN DYKE D, Allen M . Clinical management considerations in long-term survivors with trisomy 18. Pediatrics. 1990; 85(5):753-9. View

11.

Lam W, Kirk J, Manning N, Reardon W, Kelley R, Fitzpatrick D . Decreased cholesterol synthesis as a possible aetiological factor in malformations of trisomy 18. Eur J Med Genet. 2006; 49(2):195-9. DOI: 10.1016/j.ejmg.2005.05.011. View

12.

Kourie J . Interaction of reactive oxygen species with ion transport mechanisms. Am J Physiol. 1998; 275(1):C1-24. DOI: 10.1152/ajpcell.1998.275.1.C1. View

13.

Barker W, Garavelli J, Huang H, McGarvey P, Orcutt B, Srinivasarao G . The protein information resource (PIR). Nucleic Acids Res. 1999; 28(1):41-4. PMC: 102418. DOI: 10.1093/nar/28.1.41. View

14.

Baty B, Blackburn B, Carey J . Natural history of trisomy 18 and trisomy 13: I. Growth, physical assessment, medical histories, survival, and recurrence risk. Am J Med Genet. 1994; 49(2):175-88. DOI: 10.1002/ajmg.1320490204. View

15.

Makrydimas G, Plachouras N, Thilaganathan B, Nicolaides K . Abnormal immunological development in fetuses with trisomy 18. Prenat Diagn. 1994; 14(4):239-41. DOI: 10.1002/pd.1970140403. View

16.

Huang D, Sherman B, Lempicki R . Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009; 4(1):44-57. DOI: 10.1038/nprot.2008.211. View

17.

Shapiro B . Whither Down syndrome critical regions?. Hum Genet. 1997; 99(3):421-3. DOI: 10.1007/s004390050383. View

18.

Langlois D, Li J, Saez J . Development and function of the human fetal adrenal cortex. J Pediatr Endocrinol Metab. 2003; 15 Suppl 5:1311-22. View

19.

Sakabe M, Ikeda K, Nakatani K, Kawada N, Imanaka-Yoshida K, Yoshida T . Rho kinases regulate endothelial invasion and migration during valvuloseptal endocardial cushion tissue formation. Dev Dyn. 2005; 235(1):94-104. DOI: 10.1002/dvdy.20648. View

20.

Irons M, Elias E, Salen G, Tint G, Batta A . Defective cholesterol biosynthesis in Smith-Lemli-Opitz syndrome. Lancet. 1993; 341(8857):1414. DOI: 10.1016/0140-6736(93)90983-n. View